Clinical Trial Detail

NCT ID NCT02684227
Title Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

endometrial cancer

Therapies

Carboplatin + Enzalutamide + Paclitaxel

Age Groups: adult

No variant requirements are available.